MedTrace Logo

Kalifilcon A Toric Compared to Commercially Available Lenses

NCT06098937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-12-10

Study results available
· View outcomes & findings →

Summary

Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.

Conditions

  • Astigmatism

Interventions

DEVICE

Kalifilcon Toric Lens

Kalifilcon A Daily Disposable Toric for Ametropia

DEVICE

Total1 for Astigmatism

Total1 for Astigmatism

DEVICE

Precision1 for Astigmatism

Precision1 for Astigmatism

DEVICE

MyDay Toric

MyDay Toric

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2023-09-27
Completion
2023-09-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06098937 on ClinicalTrials.gov